These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 6290053
1. Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU. Niederle N, Krischke W, Bremer K, Schmidt CG, Seeber S. Cancer Treat Rev; 1982 Jun; 9 Suppl():101-5. PubMed ID: 6290053 [No Abstract] [Full Text] [Related]
2. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO). Havemann K. Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059 [No Abstract] [Full Text] [Related]
6. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma. Cohen MH, Broder LE, Fossieck BE, Ihde DC, Minna JD. Cancer Treat Rep; 1977 Jun; 61(3):489-90. PubMed ID: 194694 [No Abstract] [Full Text] [Related]
14. Management of small cell cancer: intensive chemotherapy. Smyth JF, Gregor A. Recent Results Cancer Res; 1984 Jun; 92():58-64. PubMed ID: 6330811 [No Abstract] [Full Text] [Related]
15. Etoposide--an effective single drug for treating bronchogenic carcinoma. Anderson G, Peel ET, Cheong CM, Broderick NJ. Clin Oncol; 1982 Jun; 8(3):215-8. PubMed ID: 7140048 [No Abstract] [Full Text] [Related]
18. Early crossover of induction chemotherapy in small cell lung carcinoma. Robinson PC, Gill PG, Antic R, Drew MJ, McLennan G. Aust N Z J Med; 1983 Feb; 13(1):21-5. PubMed ID: 6309130 [No Abstract] [Full Text] [Related]